This site is intended for healthcare professionals
Insight

Targeted therapies in HER2 negative breast cancer

Read time: 5 mins
Last updated:23th Aug 2019
Published:9th Aug 2019
Source: Medthority
In the third part of our four-part series detailing targeted breast cancer therapies, we focus on the HER2 negative subtype that is more difficult to treat than HER2 positive breast cancers.
Register free for full access to medthority.com